2007.09.23: September 23, 2007: Headlines: COS - Tonga: Medicine: Epidemiology: Cancer: Seattle Times: Tonga RPCV Laura Koutsky developed breakthrough vaccine against cervical cancer

Peace Corps Online: Directory: Tonga: Peace Corps Tonga : Peace Corps Tonga: New Stories: 2007.09.23: September 23, 2007: Headlines: COS - Tonga: Medicine: Epidemiology: Cancer: Seattle Times: Tonga RPCV Laura Koutsky developed breakthrough vaccine against cervical cancer

By Admin1 (admin) (pool-151-196-232-73.balt.east.verizon.net - on Sunday, October 14, 2007 - 12:54 pm: Edit Post

Tonga RPCV Laura Koutsky developed breakthrough vaccine against cervical cancer

Tonga RPCV Laura Koutsky developed breakthrough vaccine against cervical cancer

Koutsky landed in the South Pacific kingdom of Tonga with an array of colorful homemade dresses and her usual enthusiasm. She credits the Peace Corps with directing her talent, strengthening her internal resolve. "I learned there's a lot in life that isn't going to turn out the way you think it will, and you have to find solutions for problems you'd never thought you'd confront; and in the end, you will feel good if you solve these problems." She was charged with teaching high-school biology but had no textbooks, no paper, no writing utensils. There was a chalkboard. But no chalk. "So you get to be friends with the other teachers," Koutsky says, "and arrange to use their chalk when they're not using it." Luckily, Koutsky could draw. Cells, granules, organ systems. A natural teacher, she was also a great listener, recalls fellow Peace Corps volunteer Julianne Hickey. Students would go to her for additional help. They could tell if she was home by whether her black bike was parked out front. After the Peace Corps, Koutsky applied to the UW's School of Public Health with an eye toward international health. She was rejected. "They were underwhelmed by my undergraduate transcript. B-minus."

Tonga RPCV Laura Koutsky developed breakthrough vaccine against cervical cancer

From Virus To Vaccine

Professor Laura Koutsky clears a crucial path to preventing cervical cancer


The back story of the new cervical-cancer vaccine includes, among its many twists: Warts, Italian nuns, a virus old as humanity, a German scientist who shared DNA samples even with those who'd spurned him, numerous naysayers and red herrings, thousands of University of Washington student volunteers, a mended friendship — and a Peace Corps returnee who launched her pivotal career in sexually transmitted diseases (STD) through a chance encounter at the Northgate Mall.

"It didn't seem to be a linear pathway to how I got here," laughs UW epidemiology professor Laura Koutsky. She's credited with developing the world's first human papillomavirus (HPV) vaccine along with Dr. Kathrin Jansen, a yeast expert then at Merck Research Laboratories.

Human papillomaviruses are responsible for virtually all cervical cancers. Cervical cancer strikes 493,000 women every year and kills 274,000 of them, usually in their most productive years. After breast cancer, it is the second most common cancer among women. In poor countries, it is the leading cause of cancer-related death because Pap tests to screen for pre-malignant cells are not routine.

Talk about contagious! Within a year of first intercourse, a young woman has a 30 percent chance of becoming infected with HPV even if she has only one partner. Within three years, 60 percent of women are infected. By the time women are in their 40s, the infection rate is 70 to 80 percent.

Koutsky calls HPV "an equal-opportunity infection," unlike other sexually transmitted diseases that tend to hover around people who have many sexual partners. You can get HPV your first time. You can even get it through genital contact without having intercourse.

Those were the startling results of Koutsky's ground-breaking research that enlisted 900 women volunteers on the UW campus starting in the late-1980s for three years of pelvic exams, shots and detailed questions about their sex lives.

The dogma, back then, was that to learn about any sexually transmitted disease, you had to study high-risk populations at STD clinics. But Koutsky suspected that by the time people sought help at an STD clinic, they'd have already been long infected. It would be too late to figure out how and when they got the virus and how long it would take for the bug to damage cells.

So Koutsky also recruited at UW's Hall Health outpatient clinic and focused on women who'd had fewer than four sexual partners in their lives. Her important early studies, published in the New England Journal of Medicine and the American Journal of Epidemiology, examined the disease's natural history — what causes cervical cancer and HPV, who gets it and when.

Without knowing those basics, it would have been impossible to make a vaccine.

FLASH ON VACCINES, and most people think of scientists tinkering with slides and serums. (That was Jansen's realm.) Koutsky's role, as an epidemiologist, was to design studies that demonstrated the vaccines' safety and effectiveness, an endeavor considered so significant that Koutsky is first author on the scientific papers announcing the vaccine breakthroughs.

Two of Koutsky's key studies, published in 2002 and 2007 in the New England Journal, proved HPV vaccines were effective. "You can have a million vaccines out there," Koutsky says, "but do they work? Can you point to data that say this product is safe, this product is effective, it does what we think it should do in a group of people"?

In a May 10 editorial in the New England Journal, Dr. Christopher Crum writes: If the promise implicit in the study by Koutsky et al. is realized, we could, in our lifetime, see the gradual but progressive dismantling of the barriers to preventing cervical cancer. The captives of our current system — both patients and their caregivers — may be set free.

For most people, the immune system tackles and virtually clears HPV infections in one to three years. But about 15 percent of the time, the virus lingers. This can lead to warts or cancer in men, women and youths. That's why our health system promotes frequent Pap smears and removal of suspicious pre-cancerous lesions. Such intensive monitoring and treatment carries a hefty price tag, never mind the stress.

"The HPV vaccine ranks with the hepatitis B vaccine as the two most important vaccines to be given to prevent cancer," says Dr. King Holmes, chairman of the UW's Department of Global Health and director of the Center for AIDS and STD. "Laura brought the HPV vaccine trials forward in the most efficient manner possible. There were no missteps. As a result, this is a vaccine that got out to women more quickly and with all of the right considerations."

Creating a vaccine and getting it to the public was a monumental task involving hundreds of scientists, thousands of volunteers, layers of logistics on everything from syringe length to inadvertent pregnancy.

Koutsky's team had to figure out how many volunteers to recruit, how many shots to give and when, how long it takes to become infected (or not), when you have enough information to stop. They enrolled 12,167 young women in a randomized, double-blind, placebo-controlled trial at 90 sites in 15 countries and followed them for three years.

In all, it took more than two decades to create Gardasil, the new Merck vaccine that protects against four types of HPV (two cancer viruses and two wart viruses) using Koutsky's 1980s natural-history study as a starting point.

In the world of vaccines, that's fast.

LAURA KOUTSKY was born in Seattle in 1953 and grew up in the Montlake and Laurelhurst neighborhoods, the middle of five children of a surgeon dad and stay-at-home mom.

Her mother, Ruth, says Laura always knew how to make her laugh, and even as a young child would befriend underdogs. Her sister describes Laura as an artistic, happy-go-lucky kid, a cheerleader and athlete who loved swimming, water skiing, doodling and exploring around their Whidbey Island cabin. Even though their father was a doctor, Koutsky says her parents never pressured the kids to go into medicine or the sciences, though they did emphasize a responsibility to give back to society.

"I was not driven at the age of 5 to become an epidemiologist," Koutsky says. "I wasn't even driven at the age of 20!"

In retrospect, however, she recalls vaccinations were a big deal. The family's home movies chronicle childhood birthdays, Christmas morning — and the day they all got the polio vaccine.

At Roosevelt High School, a teacher sparked Koutsky's interest in biology, which became her major at the University of Oregon. One summer, she studied invertebrate zoology at the Oregon Institute of Marine Biology outside Coos Bay. Every day, she wandered the tide flats for hours in hip waders. "It was fascinating. It had to do with patterns and relationships and evolution. Worms. Insects, mammals."

Yet she soon realized careers in marine biology begin by washing a lot of glassware on research vessels. A friend suggested the Peace Corps.

Koutsky landed in the South Pacific kingdom of Tonga with an array of colorful homemade dresses and her usual enthusiasm. She credits the Peace Corps with directing her talent, strengthening her internal resolve.

"I learned there's a lot in life that isn't going to turn out the way you think it will, and you have to find solutions for problems you'd never thought you'd confront; and in the end, you will feel good if you solve these problems."

She was charged with teaching high-school biology but had no textbooks, no paper, no writing utensils. There was a chalkboard. But no chalk. "So you get to be friends with the other teachers," Koutsky says, "and arrange to use their chalk when they're not using it."

Luckily, Koutsky could draw. Cells, granules, organ systems. A natural teacher, she was also a great listener, recalls fellow Peace Corps volunteer Julianne Hickey. Students would go to her for additional help. They could tell if she was home by whether her black bike was parked out front. After the Peace Corps, Koutsky applied to the UW's School of Public Health with an eye toward international health. She was rejected. "They were underwhelmed by my undergraduate transcript. B-minus."

Around that time, while shopping at Northgate, she ran into a former junior-high classmate who was headed to medical school and leaving behind her job as research assistant in the lab of King Holmes, a world expert on sexually transmitted diseases.

"I wouldn't recommend just anybody for my job," Julie Adam says. "But I had always believed in Laura. She's very intelligent, she has ethics, a big heart. She was able to bridge many groups of people. And she's a hard worker."

Over the next year, while gathering data about chlamydia in pregnancy, Koutsky fell in love with epidemiological research. "The idea of being able to ask questions about what was causing a disease!" She was immersed in patterns and relationships, just like during her beloved summer on the tide flats, only this time in a landscape of diseases and populations. It was like being a detective investigating the links between humans, environment, behaviors, organisms and disease.

Koutsky also realized she loved the dynamics of working with scientists who hypothesized, challenged each other's ideas and contributed different bits to solve a problem: Collaboration. The UW School of Public Health accepted her the following year, and she eventually pursued a doctorate in epidemiology, all the while continuing to work in Holmes' lab.

"She came in here with her eyes wide open ready to take on anything," Holmes recalls. "My initial impression was that she was incredibly enthusiastic and at the same time very level-headed. It became apparent as we worked on many different projects that everything she put her hand to came out successfully."

Come time for her dissertation project, Koutsky proposed studying the link between sexually transmitted diseases and spontaneous miscarriages. Holmes thought the project would be problematic and costly.

Besides, HPV was rising on the horizon as the next big sexually transmitted disease. He wanted Koutsky to tackle it. "She'd worked on 14 different STDs and was unique in having so much experience . . . Of all the young people we had coming along, she was the best prepared to handle it."

HUMAN PAPILLOMAVIRUSES evolved with humans a million years ago. Ancient Greeks and Romans described genital warts thousands of years ago. But for most of human history, no one understood how sex, HPV and cancer were linked.

People had long suspected a relationship between cervical cancer and sex. In 1842, Italian physician D. Rigoni-Stern reported that nuns had virtually no cases of the disease; cervical cancer was rare among married women; the rate among prostitutes was unusually high. By the 1900s, it became clear. Women with more sex partners were more likely to get cervical cancer.

By the 1960s, researchers surmised that one or more sexually transmitted diseases caused cervical cancer — perhaps herpes or chlamydia, they thought. Then, in the 1970s, Harald zur Hausen, a German cancer researcher training at the University of Pennsylvania, bucked conventional wisdom, demonstrating that HPV was a family of viruses that caused everything from common warts to malicious cancers of the cervix, and more rarely, of the anus, penis, mouth and neck. Until then, nobody realized certain viruses could cause cancer.

Zur Hausen freely shared with labs worldwide the viral-DNA fragments he'd painstakingly isolated, an act credited with speeding up vaccine research. (And unlikely to happen now, Koutsky says, in an age when everyone wants to patent everything.)

Your skin, right now, is probably covered in human papillomavirus; there are more than 200 types. Two, HPV-16 and HPV-18, cause 70 percent of all cervical cancers.

Koutsky's natural-history studies proved a strong temporal relationship between cervical cancer and those two. Soon after becoming infected with those virus types, women developed abnormal cells; sometimes these progressed to lesions, including the sort that typically turn into cancer. (In the study, lesions were removed before becoming cancerous.)

The fact that it took only months to go from infection to bad Pap — instead of 10 to 20 years as previously thought — meant it would be realistic to test a vaccine.

"No one believed it," says Dr. Nancy Kiviat, who collaborated with Koutsky on the natural-history study and now directs pathology/cytopathology at Harborview Medical Center. It was Kiviat who developed the assays to test whether women in Koutsky's early study had HPV and which type. Not an easy task.

"Now, everybody gets the same answer and tests are more standardized," says Denise Galloway, a microbiologist and collaborator on the natural-history study. "In the late '80s, early '90s, everybody was using different techniques, and the results were a mess. HPV was everywhere or was nowhere."

To double-check lab results, dual samples from each woman were sent to different labs. The results should've matched. Not even close. Kiviat worried her lab was wrong. Koutsky pored over the data and recognized consistent patterns in Kiviat's results. These are right, she reassured her colleague.

Koutsky credits Kiviat with teaching her the power of collaboration. Early in their careers, the two were icy competitors, each recalls. After about a year, Kiviat approached Koutsky:

You know, as a pathologist, I'm going to develop lab expertise and clinical expertise and you'll have the epidemiologic, analytic, biostatistical expertise. If we work together, we could have the world!

The rivalry melted. They became lifelong friends and collaborators, Kiviat's lab central to the success of Koutsky's studies.

Around the same time, DNA technology was moving forward. Until then, the problem with HPV was that you couldn't grow it in a lab, ruling out a vaccine based on live or attenuated HPV virus. New molecular technology made it (theoretically) possible to snip fragments of viral DNA and insert them into a vehicle that could infect the cell systems of insects or yeast. That would produce a capsid protein, or viral shell, that could stimulate an immune response without transmitting disease.

Enter Kathrin Jansen, a scientist at Merck with expertise in yeast. She was a newcomer to the HPV field when she met Koutsky at a conference.

Jansen believed she could use yeast to make an HPV vaccine; Merck had already made a hepatitis B vaccine using a similar concept. She needed Koutsky's HPV expertise to design a vaccine trial. Jansen: "If you design a study wrong, involve too few people, you can have a trial that will not reach statistical significance."

Koutsky's team enrolled 2,392 young women in a double-blind trial to test the HPV-16 vaccine Jansen had created (an arduous years-of-late-nights-in-lab process using a dozen different yeast strains).

The volunteers received three doses of either placebo or vaccine and underwent Pap tests about every six months. Koutsky's team figured that by the time 31 women had persistent HPV-16 infection they'd know whether the vaccine had any impact. After 17 months, the 31st woman tested positive for persistent HPV-16. The study was unblinded to a biostatistician. All of the persistent HPV-16 infections were in women who'd received the placebo. None of the vaccinated women had the virus.

"We were clapping and jumping through the hallways" at Merck, Jansen recalls. Immediately, they phoned Koutsky with the good news. Was it by chance that a vaccine for women was developed by women? Coincidence, Jansen says. "But then, it was a lot of fun to have it go that way."

Next decision: Which strains of HPV to include in the vaccine that would go to the public? Everyone agreed two of the four spots should go to HPV-16 and HPV-18, the virus types causing most cervical cancer. Koutsky wanted to fill the other two slots with two more cancer types. Jansen argued for a couple of genital wart virus types to make the vaccine appealing to men.

Because men don't have cervixes, they can't get cervical cancer. But like mosquitoes that transmit malaria to humans, men carry and transmit HPV to women. (Men who have sex with men are also at risk for anal cancer.) If both men and women were vaccinated, HPV rates might decrease faster in the general population, an effect known as herd immunity.

"Look, Laura," Jansen said. "So what makes it palatable for a young man to get immunized if he doesn't get a benefit for himself? You count on the goodwill of that person? You know, I imagine it must be quite devastating to have one of those big, ugly things growing on his penis, right? Certainly not very attractive, and the treatment is not particularly pleasant . . ."

Koutsky was convinced.

Licensed last summer, the Merck vaccine protects against two cancer viruses and two genital wart viruses. It's targeted at girls around age 12, before they become sexually active. That makes it controversial among parents who worry the vaccine could encourage sexual relationships.

Parents have to look at facts, the epidemiologist says: 40 percent of 16-year-old girls are sexually active; 70 percent of 18-year-old girls are. Washington state fully covers the vaccine for girls 18 and younger. At $360 for the three-dose series, that's a significant savings.

Now that Koutsky's developed the vaccine, she's on to the next challenge: Getting it to the public. "It would be a travesty if we have this highly safe and effective vaccine and it doesn't get used."

Paula Bock is a Pacific Northwest magazine staff writer. Email: pbock@seattletimes.com. Benjamin Benschneider is a magazine staff photographer.

Links to Related Topics (Tags):

Headlines: September, 2007; Peace Corps Tonga; Directory of Tonga RPCVs; Messages and Announcements for Tonga RPCVs; Medicine; Cancer

When this story was posted in October 2007, this was on the front page of PCOL:

Contact PCOLBulletin BoardRegisterSearch PCOLWhat's New?

Peace Corps Online The Independent News Forum serving Returned Peace Corps Volunteers RSS Feed
Senator Dodd's Peace Corps Hearings Date: July 25 2007 No: 1178 Senator Dodd's Peace Corps Hearings
Read PCOL's executive summary of Senator Chris Dodd's hearings on July 25 on the Peace Corps Volunteer Empowerment Act and why Peace Corps Director Ron Tschetter does not believe the bill would contribute to an improved Peace Corps while four other RPCV witnesses do. Highlights of the hearings included Dodd's questioning of Tschetter on political meetings at Peace Corps Headquarters and the Inspector General's testimony on the re-opening of the Walter Poirier III investigation.

Peace Corps News Peace Corps Library Peace corps History RPCV Directory Sign Up

What is the greatest threat facing us now?  Date: September 12 2007 No: 1195 What is the greatest threat facing us now?
"People will say it's terrorism. But are there any terrorists in the world who can change the American way of life or our political system? No. Can they knock down a building? Yes. Can they kill somebody? Yes. But can they change us? No. Only we can change ourselves. So what is the great threat we are facing? I would approach this differently, in almost Marshall-like terms. What are the great opportunities out there - ones that we can take advantage of?" Read more.

September 2, 2007: This Month's Top Stories Date: September 6 2007 No: 1193 September 2, 2007: This Month's Top Stories
Blackwill has contract to undermine Iraqi government 29 Aug
Frank Delano returns to Ghana 31 Aug
Mike Honda's comfort woman resolution passes 28 Aug
Margaret Pratley at 81 is oldest PCV 23 Aug
"Pepo" Saavedra Iguina sings with heart of poet 23 Aug
Campbell's mother recalls her daughter in testimony 22 Aug
Ex-Americorps head appointed Associate Director 20 Aug
Tschetter in Paraguay for 40th anniversary of program 20 Aug
Niki Tsongas is front-runner for Congressional seat 19 Aug
Mike Sheppard announces Peace Corps Wiki 16 Aug
Mark Schneider writes: Getting answers on Pakistan 15 Aug
Al Kamen writes: A Little Iraq Nostalgia 15 Aug
Victor DeMasi studies butterflies 14 Aug
Obituary for Morocco Country Director Everett Woodman 13 Aug
Carol Miles helps increase African seed production 13 Aug
Bruce Anderson back at Anderson Valley Advertiser 13 Aug
Joe Keefe writes: Dodd deserves the Oval Office 13 Aug
Malaysia RPCVs find each other after 35 years 10 Aug
Molly Brown monitors farms from space 10 Aug
Colin Gallagher writes: Surveillance of US Citizens 8 Aug
Scott Lacy starts African Sky 6 Aug
Charles Murray to address Centre for Independent Studies 6 Aug

Paul Theroux: Peace Corps Writer Date: August 15 2007 No: 1185 Paul Theroux: Peace Corps Writer
Paul Theroux began by writing about the life he knew in Africa as a Peace Corps Volunteer. His first first three novels are set in Africa and two of his later novels recast his Peace Corps tour as fiction. Read about how Theroux involved himself with rebel politicians, was expelled from Malawi, and how the Peace Corps tried to ruin him financially in John Coyne's analysis and appreciation of one of the greatest American writers of his generation (who also happens to be an RPCV).

August 4, 2007: This Month's Top Stories Date: August 5 2007 No: 1182 August 4, 2007: This Month's Top Stories
Peace Corps reopens Guinea Program 19 Jul
China beating US in public diplomacy 4 Aug
Shalala continues fight for wounded soldiers 4 Aug
Sue Hilderbrand's goal is stopping funding for Iraq war 3 Aug
Matthew Barison went from Uzbekistan to Romania 2 Aug
Peter Chilson writes "Disturbance-Loving Species" 31 Jul
An RPCV remembers Texas Tower Tragedy 29 Jul
Daniel Balluff films documentaries on Niger 28 Jul
Renewing the Bond of Trust with PCVs 27 Jul
Carol Bellamy to chair Fair Labor Foundation 25 Jul
Delay in Julia Campbell trial 24 Jul
PCV Brian writes: Secondary Projects - First Priority 23 Jul
Dodd says no easy election for Democrats in 2008 22 Jul
John Smart writes: Bush's palace in Iraq 20 Jul
Bill Moyers eulogizes Lady Bird Johnson 15 Jul
Social Justice ranks high on Dan Weinberg’s agenda 15 Jul
PCV Tait writes: Good-bye to my village 14 Jul
Amy Smith organizes Development Design Summit 13 Jul
Cameron Quinn to head PC Third Goal Office 11 Jul
Josh Yardley brought Red Sox to Burkina Faso 11 Jul
James Rupert writes: Islamabad's Red Mosque 11 Jul
Sarah Chayes writes: NATO didn't lose Afghanistan 10 Jul

Dodd issues call for National Service Date: June 26 2007 No: 1164 Dodd issues call for National Service
Standing on the steps of the Nashua City Hall where JFK kicked off his campaign in 1960, Presidential Candidate Chris Dodd issued a call for National Service. "Like thousands of others, I heard President Kennedy's words and a short time later joined the Peace Corps." Dodd said his goal is to see 40 million people volunteering in some form or another by 2020. "We have an appetite for service. We like to be asked to roll up our sleeves and make a contribution," he said. "We haven't been asked in a long time."

July 9, 2007: This Month's Top Stories Date: July 10 2007 No: 1172 July 9, 2007: This Month's Top Stories
O'Hanlon says "soft partition" occurring in Iraq 9 Jul
Eric R. Green writes on coming oil crisis 8 Jul
Why Dodd joined the Peace Corps 5 Jul
Jim Doyle positioned for third term 5 Jul
Michael Adlerstein to direct UN Master Plan 3 Jul
Shalala says Veterans report will be solution driven 1 Jul
Blackwill says: No process will make up for stupidity 30 Jun
Allan Reed creates a Diaspora Skills Transfer Program 29 Jun
State Dept apology ends hold on Green nomination 28 Jun
Call for stories to celebrate PC 50th Anniversary 25 Jun
Michael Shereikis is singer and guitarist for Chopteeth 25 Jun
Christopher R. Hill Visits North Korea 22 Jun
Tschetter at JFK Bust Unveiling Ceremony 21 Jun
Kiribati too risky for PCVs 17 Jun
James Rupert writes: US calls for free Pakistani elections 17 Jun
Colin Cowherd says PCVs are losers 7 Jun
Tony Hall Warns of Food Shortages in North Korea 7 Jun
Youth Theatre performs Spencer Smith's "Voices from Chernobyl" 7 Jun
Ifugao names forest park after Julia Campbell 6 Jun
Anissa Paulsen assembles "The Many Colors of Islam" 5 Jun
Obituary for Nepal RPCV Loret Miller Ruppe 2 Jun
Forty PCVS to arrive in Ethiopia 2 Jun

Public diplomacy rests on sound public policy Date: June 10 2007 No: 1153 Public diplomacy rests on sound public policy
When President Kennedy spoke of "a long twilight struggle," and challenged the country to "ask not," he signaled that the Cold War was the challenge and framework defining US foreign policy. The current challenge is not a struggle against a totalitarian foe. It is not a battle against an enemy called "Islamofascism." From these false assumptions flow false choices, including the false choice between law enforcement and war. Instead, law enforcement and military force both must be essential instruments, along with diplomacy, including public diplomacy. But public diplomacy rests on policy, and to begin with, the policy must be sound. Read more.

Ambassador revokes clearance for PC Director Date: June 27 2007 No: 1166 Ambassador revokes clearance for PC Director
A post made on PCOL from volunteers in Tanzania alleges that Ambassador Retzer has acted improperly in revoking the country clearance of Country Director Christine Djondo. A statement from Peace Corps' Press Office says that the Peace Corps strongly disagrees with the ambassador’s decision. On June 8 the White House announced that Retzer is being replaced as Ambassador. Latest: Senator Dodd has placed a hold on Mark Green's nomination to be Ambassador to Tanzania.

Peace Corps Funnies Date: May 25 2007 No: 1135 Peace Corps Funnies
A PCV writing home? Our editor hard at work? Take a look at our Peace Corps Funnies and Peace Corps Cartoons and see why Peace Corps Volunteers say that sometimes a touch of levity can be one of the best ways of dealing with frustrations in the field. Read what RPCVs say about the lighter side of life in the Peace Corps and see why irreverent observations can often contain more than a grain of truth. We'll supply the photos. You supply the captions.

PCOL serves half million Date: May 1 2007 No: 1120 PCOL serves half million
PCOL's readership for April exceeded 525,000 visitors - a 50% increase over last year. This year also saw the advent of a new web site: Peace Corps News that together with the Peace Corps Library and History of the Peace Corps serve 17,000 RPCVs, Staff, and Friends of the Peace Corps every day. Thanks for making PCOL your source of news for the Peace Corps community. Read more.

Suspect confesses in murder of PCV Date: April 27 2007 No: 1109 Suspect confesses in murder of PCV
Search parties in the Philippines discovered the body of Peace Corps Volunteer Julia Campbell near Barangay Batad, Banaue town on April 17. Director Tschetter expressed his sorrow at learning the news. “Julia was a proud member of the Peace Corps family, and she contributed greatly to the lives of Filipino citizens in Donsol, Sorsogon, where she served,” he said. Latest: Suspect Juan Duntugan admits to killing Campbell. Leave your thoughts and condolences .

The Peace Corps Library Date: July 11 2006 No: 923 The Peace Corps Library
The Peace Corps Library is now available online with over 40,000 index entries in 500 categories. Looking for a Returned Volunteer? Check our RPCV Directory or leave a message on our Bulletin Board. New: Sign up to receive our free Monthly Magazine by email, research the History of the Peace Corps, or sign up for a daily news summary of Peace Corps stories. FAQ: Visit our FAQ for more information about PCOL.

He served with honor Date: September 12 2006 No: 983 He served with honor
One year ago, Staff Sgt. Robert J. Paul (RPCV Kenya) carried on an ongoing dialog on this website on the military and the peace corps and his role as a member of a Civil Affairs Team in Iraq and Afghanistan. We have just received a report that Sargeant Paul has been killed by a car bomb in Kabul. Words cannot express our feeling of loss for this tremendous injury to the entire RPCV community. Most of us didn't know him personally but we knew him from his words. Our thoughts go out to his family and friends. He was one of ours and he served with honor.

Read the stories and leave your comments.

Some postings on Peace Corps Online are provided to the individual members of this group without permission of the copyright owner for the non-profit purposes of criticism, comment, education, scholarship, and research under the "Fair Use" provisions of U.S. Government copyright laws and they may not be distributed further without permission of the copyright owner. Peace Corps Online does not vouch for the accuracy of the content of the postings, which is the sole responsibility of the copyright holder.

Story Source: Seattle Times

This story has been posted in the following forums: : Headlines; COS - Tonga; Medicine; Epidemiology; Cancer


Add a Message

This is a public posting area. Enter your username and password if you have an account. Otherwise, enter your full name as your username and leave the password blank. Your e-mail address is optional.